NM_021954.4:c.1017G>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_021954.4(GJA3):​c.1017G>A​(p.Ala339Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.212 in 1,561,404 control chromosomes in the GnomAD database, including 36,453 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3252 hom., cov: 33)
Exomes 𝑓: 0.21 ( 33201 hom. )

Consequence

GJA3
NM_021954.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.07

Publications

17 publications found
Variant links:
Genes affected
GJA3 (HGNC:4277): (gap junction protein alpha 3) The protein encoded by this gene is a connexin and is a component of lens fiber gap junctions. Defects in this gene are a cause of zonular pulverulent cataract type 3 (CZP3). [provided by RefSeq, Jan 2010]
GJA3 Gene-Disease associations (from GenCC):
  • cataract 14 multiple types
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • early-onset nuclear cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset posterior polar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pulverulent cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 13-20142272-C-T is Benign according to our data. Variant chr13-20142272-C-T is described in ClinVar as Benign. ClinVar VariationId is 261457.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GJA3NM_021954.4 linkc.1017G>A p.Ala339Ala synonymous_variant Exon 2 of 2 ENST00000241125.4 NP_068773.2 Q9Y6H8
GJA3XM_011535048.3 linkc.1017G>A p.Ala339Ala synonymous_variant Exon 2 of 2 XP_011533350.1 Q9Y6H8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GJA3ENST00000241125.4 linkc.1017G>A p.Ala339Ala synonymous_variant Exon 2 of 2 3 NM_021954.4 ENSP00000241125.3 Q9Y6H8
ENSG00000299362ENST00000762843.1 linkn.133+4270C>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.201
AC:
30520
AN:
152096
Hom.:
3248
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.162
Gnomad AMI
AF:
0.243
Gnomad AMR
AF:
0.196
Gnomad ASJ
AF:
0.210
Gnomad EAS
AF:
0.308
Gnomad SAS
AF:
0.307
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.331
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.243
GnomAD2 exomes
AF:
0.223
AC:
37260
AN:
167114
AF XY:
0.232
show subpopulations
Gnomad AFR exome
AF:
0.179
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.221
Gnomad EAS exome
AF:
0.313
Gnomad FIN exome
AF:
0.192
Gnomad NFE exome
AF:
0.214
Gnomad OTH exome
AF:
0.226
GnomAD4 exome
AF:
0.213
AC:
299747
AN:
1409202
Hom.:
33201
Cov.:
41
AF XY:
0.216
AC XY:
150557
AN XY:
697494
show subpopulations
African (AFR)
AF:
0.167
AC:
5116
AN:
30696
American (AMR)
AF:
0.160
AC:
6093
AN:
38044
Ashkenazi Jewish (ASJ)
AF:
0.220
AC:
5533
AN:
25136
East Asian (EAS)
AF:
0.277
AC:
10017
AN:
36122
South Asian (SAS)
AF:
0.300
AC:
24046
AN:
80190
European-Finnish (FIN)
AF:
0.183
AC:
8458
AN:
46150
Middle Eastern (MID)
AF:
0.300
AC:
1691
AN:
5644
European-Non Finnish (NFE)
AF:
0.207
AC:
225428
AN:
1088782
Other (OTH)
AF:
0.229
AC:
13365
AN:
58438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
14194
28388
42581
56775
70969
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8004
16008
24012
32016
40020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.201
AC:
30535
AN:
152202
Hom.:
3252
Cov.:
33
AF XY:
0.203
AC XY:
15115
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.162
AC:
6710
AN:
41530
American (AMR)
AF:
0.196
AC:
3004
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.210
AC:
730
AN:
3470
East Asian (EAS)
AF:
0.308
AC:
1593
AN:
5166
South Asian (SAS)
AF:
0.306
AC:
1477
AN:
4822
European-Finnish (FIN)
AF:
0.188
AC:
1992
AN:
10610
Middle Eastern (MID)
AF:
0.334
AC:
97
AN:
290
European-Non Finnish (NFE)
AF:
0.209
AC:
14191
AN:
67994
Other (OTH)
AF:
0.246
AC:
520
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1269
2538
3806
5075
6344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
1579
Bravo
AF:
0.199
Asia WGS
AF:
0.286
AC:
991
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Cataract 14 multiple types Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
1.7
DANN
Benign
0.85
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11617415; hg19: chr13-20716411; COSMIC: COSV53834078; API